Kopin Corporation announced that it intends to offer and sell shares of its common stock and pre-funded warrants in a public offering. All of the securities to be sold in the offering are to be offered by Kopin. Kopin intends to use the net proceeds from the offering to fund general corporate purposes, including working capital, funding internal research and development and neural display, capital expenditures, and for any payments related to pending litigation judgements or any appeals of the judgements. Canaccord Genuity is acting as the sole bookrunner for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KOPN:
- Kopin gets 2nd production order for CR3 from HMDmd
- Kopin receives additional $2M follow-on production order
- Kopin Enhances Board with Semiconductor Expert Paul Walsh
- Kopin awarded first order for 2K-R11 FLCoS Spatial Light Modulator
- Kopin gets Nasdaq letter informing that compliance regained on bid rule